Potassium Replacement Guidelines

Introduction to Hypokalemia Treatment

The American College of Cardiology recommends oral potassium chloride 20-60 mEq/day to maintain serum potassium in the 4.0-5.0 mEq/L range, with intravenous replacement reserved for severe cases (K+ <2.5 mEq/L), cardiac manifestations, or inability to take oral medications 1

For mild hypokalemia (3.0-3.5 mEq/L), oral replacement is sufficient for most patients without cardiac symptoms or ECG changes, with a dose of 20-40 mEq/day in divided doses 1, 2
In moderate hypokalemia (2.5-2.9 mEq/L), oral potassium chloride 40-60 mEq/day in divided doses is typically adequate, with ECG monitoring recommended due to increased arrhythmia risk 1, 2
Severe hypokalemia (K+ <2.5 mEq/L) requires immediate IV replacement with continuous cardiac monitoring, and a maximum peripheral IV concentration of 40 mEq/L 1, 2

Hypomagnesemia is the most common cause of refractory hypokalemia and must be corrected before potassium levels will normalize, as magnesium depletion causes dysfunction of potassium transport systems and increases renal potassium excretion 1, 2
Diuretic therapy is the most frequent cause of hypokalemia, and potassium-sparing diuretics are preferred over supplements for diuretic-induced hypokalemia 1

In heart failure patients, the target serum potassium is 4.0-5.0 mEq/L, and potassium-sparing diuretics are preferred over supplements for diuretic-induced hypokalemia 1, 2
In diabetic ketoacidosis, delay insulin therapy until K+ ≥3.3 mEq/L to prevent life-threatening arrhythmias, and add 20-30 mEq potassium to each liter of IV fluid once K+ <5.5 mEq/L and adequate urine output is established 1, 2
In patients on kidney replacement therapy, use dialysis solutions containing potassium, phosphate, and magnesium to prevent electrolyte disorders, and hypokalemia prevalence can reach 25% in patients on prolonged KRT modalities 3

During active replacement, recheck serum K+ within 1-2 hours after IV infusion, and within 2-3 days initially for oral potassium, then at 7 days 1
In the maintenance phase, check potassium and renal function 1-2 weeks after each dose adjustment, and at 3 months, then every 6 months thereafter 1

Digoxin should be avoided in severe hypokalemia, as it dramatically increases the risk of life-threatening arrhythmias, and correct K+ before administering 1
Potassium-sparing diuretics are more effective than oral supplements for persistent diuretic-induced hypokalemia, but should be avoided in patients with GFR <45 mL/min due to hyperkalemia risk 1

20 mEq oral potassium supplementation typically produces serum changes of 0.25-0.5 mEq/L, with a highly variable response depending on total body deficit, ongoing losses, and concurrent medications 1